Chlamydia Trachomatis antibody (FITC)

Catalog No. ABIN112694

Product Details anti-Chlamydia Trachomatis Antibody (FITC)

Target: Chlamydia Trachomatis

Reactivity: Chlamydia trachomatis

Host: Rabbit

Clonality: Polyclonal

Conjugate: This Chlamydia Trachomatis antibody is conjugated to FITC

Application: Immunofluorescence (IF)

Immunogen: L2 + other serovar groups

Application Details

Application Notes: Suitable for use in direct IFA. Acetone fixation of the antigen source is recommended prior to staining.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 4-5 mg/mL (OD280 nm, E0.1% = 1.4)

Buffer: 0.01 M PBS, pH 7.2 containing 10 mg/mL BSA as stabilizer and 0.09 % sodium azide as preservative.

Preservative: Sodium azide

Precaution of Use: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Avoid repeated freezing and thawing. This product is photosensitive and should be protected from light

Storage: 4 °C/-20 °C

Storage Comment: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Target Details for Chlamydia Trachomatis

Target: Chlamydia Trachomatis

Abstract: Chlamydia Trachomatis Products

Target Type: Bacteria

Background: Chlamydia trachomatis is an intracellular organism. Chlamydia usually infects the cervix and fallopian tubes of women and the urethra of men. Chlamydial infections are believed to be one of the most common of all STDs. It is generally thought that in a population of 15 million, there are up to 300,000 cases of chlamydia each year. Thus, there are many undiagnosed cases of chlamydia in the community. It has been estimated that the true prevalence of chlamydia in the sexually active population may be in the order of 5 % to 10 %. Chlamydia is one of the leading causes of blindness in underdeveloped countries.